City

Boston (1)

Seattle (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Fred Hutchinson Cancer Center (1)

Massachusetts General Hospital (1)

Collaborator

Incyte Corporation (1)

Jazz Pharmaceuticals (1)

Intervention

doxorubicin (1)

itacitinib (1)

laboratory biomarker analysis (1)

lurbinectedin (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Other (2)

Study Type

Interventional (2)

advanced leiomyosarcoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle

Recruiting

Metastatic Leiomyosarcoma
+17 more

Itacitinib
Laboratory Biomarker Analysis

Seattle, Washington

Fred Hutch/University of Washington Cancer Consortium

Oct 13, 2022

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma, Advanced Leiomyosarcoma Trial in Boston (Lurbinectedin,

Recruiting

Advanced Soft-tissue Sarcoma
+3 more

Boston, Massachusetts
+1 more

Feb 14, 2022